Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113256
Status:
TERMINATED
Last Update Posted:
2013-01-23
First Post:
2005-06-06
Brief Title:
Orathecin Gemcitabine Versus Placebo Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
Sponsor:
Astex Pharmaceuticals Inc
Organization:
Astex Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-02
Start Date Type:
None
Primary Completion Date:
2006-02
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-06-06
First Submit QC Date:
June 6 2005
Study First Post Date:
2005-06-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-01
Last Update Post Date:
2013-01-23
Last Update Post Date Type:
ESTIMATED